3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Ganglioneuroblastoma
1
Interventions
Lenalidomide
6
Dexamethasone
6
Cyclophosphamide
5
Bortezomib
5
fludarabine
3
carfilzomib
3
belantamab mafodotin
3
pomalidomide
2
fludarabine phosphate
2
Melphalan
2
Etoposide
2
pembrolizumab
1
isatuximab
1
elotuzumab
1
daratumumab
1
Whole-Body Irradiation
1
Thalidomide
1
Tacrolimus
1
Sirolimus
1
Resistance Training
1
Radiotherapy
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Methotrexate
1
Exercise
1
Equipment and Supplies
1
Doxorubicin
1
Cyclosporine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Influenza Vaccines
×
90 days
×
Clear all
No trials found.